24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: More People Are Dying During the Pandemic – and Not Just From COVID-19Antiviral Drugs Tied to Heart Issue in COVID-19 PatientsMost Survivors of Severe COVID-19 Report Symptoms Many Weeks After 'Recovery'Terrifying Delirium Can Strike Hospitalized COVID-19 PatientsCold War Antiseptic May Be Valuable Germ FighterWith Social Distancing, Schools Should Be Safe to Reopen This Fall, Experts SayU.S. Sees Another Record-Breaking Day of New Coronavirus Cases'Aerosol Boxes' Meant to Protect COVID Health Teams Might Harm Them: StudyAHA News: Where Do New Viruses Like the Coronavirus Come From?Blood Test May Reveal Concussion Severity With Accuracy of Spinal TapIn Many Cases, Hip Replacement Also Eases Back Pain'Broken Heart Syndrome' Has Risen During Pandemic: StudyCoronavirus Fears Kept Many Essential Workers at Home in April: StudyExposure to Iodine in the NICU May Affect Infant Thyroid FunctionA Dangerous Antibiotic-Resistant Bacteria May Now Lurk in U.S. Water, SoilZika May Have Damaged More Infants' Brains Than ExpectedU.S. Air Pollution Still at Deadly Levels, Study FindsCOVID-19 Outbreaks at Meat Processing Plants Are Hitting Minorities HardU.S. Coronavirus Cases Near 3 Million as Hospitals in Sun Belt Fill Up With PatientsAHA News: Months After Infection, Many COVID-19 Patients Can't Shake IllnessCoronavirus Ups Anxiety, Depression in the LGBTQ CommunityMajor Medical Groups Urge Americans to Wear Face MasksBlack Patients Fare Worse After AngioplastyHow Immune System Fights COVID-19 May Be Key to Vaccine SuccessWill the COVID-19 Pandemic Leave a Mental Health Crisis in Its Wake?New U.S. Coronavirus Cases Hit Another HighMultiple Surgeries for Cleft Lip, Palate Won't Cause Major Psychological DamageHIV May Not Worsen COVID-19 OutlookU.S. Coronavirus Hospitalizations Spiking in South, WestAHA News: To Everything There Is a Season, Including Heart DiseaseAsthma, Allergies Plus Pandemic May Pose 4th of July ChallengesStroke Appears 8 Times More Likely With COVID Than With FluCOVID-19 Death Risk Twice as High in New York City as Some CountriesFireworks Are Bad News for Your LungsScientists Find Source of COVID ClotsNew U.S. Coronavirus Cases Top 50,000 as More States Slow Reopening PlansNumbers of Non-COVID-19 Deaths Up During PandemicNo Good Evidence on Accuracy of Coronavirus Antibody Tests: StudyAHA News: COVID-19 Pandemic Brings New Concerns About Excessive DrinkingMuscle Relaxants for Back Pain Are Soaring: Are They Safe?Trauma of Racism Fuels High Blood Pressure Among Black Americans: StudyCOVID-19 Blood Test Might Predict Who Will Need a VentilatorWhat's the Best DIY Face Mask Against COVID-19?Deep Brain Stimulation May Slow Parkinson's, Study FindsU.S. Could See 100,000 New Cases of COVID-19 Each Day, Fauci SaysGlobally, COVID-19 Cases May Stretch Far Beyond Official Numbers: StudyFBI: Beware of Scammers Selling Fake COVID-19 Antibody TestsAHA News: Sadness and Isolation of Pandemic Can Make Coping With Grief HarderVaping-Related Lung Injuries Still Happening -- And May Look Like COVID-19Most With Coronavirus Not Sure How They Caught It: CDC
Questions and AnswersLinks
Related Topics

Diabetes

One-Time Treatment Eases Parkinson's -- in Mice

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Jun 24th 2020

new article illustration

WEDNESDAY, June 24, 2020 (HealthDay News) -- In findings that could pave the way to a new treatment for Parkinson's disease, scientists have figured out how to spur the production of new brain cells in mice.

The advance centers on a protein found in various cells in mice and humans. Researchers found that blocking it in the mouse brain caused certain "support cells" there to transform into specialized neurons that produce the chemical dopamine.

In Parkinson's disease, dopamine-producing brain cells gradually die off, leading to movement symptoms like tremors, stiff limbs and coordination problems.

In the new study, lab mice that grew new neurons also showed improvements in Parkinson-like movement problems.

Experts stressed that mice, of course, are not humans. And much more research is needed to see whether the approach could be safe and effective for people with Parkinson's, or other degenerative brain diseases such as Alzheimer's.

"But the prospect of using this general approach is exciting," said James Beck, chief scientific officer for the Parkinson's Foundation.

Beck, who was not involved in the research, said the work fits into a broader concept called "transdifferentiation" -- where one type of cell in the body is coaxed to convert into a different type. In theory, the approach could be used to replace damaged tissue in a host of conditions, from heart disease to diabetes to spinal cord injuries.

"It's exciting to think about the possibility of taking cells that are already in place in the body, and converting them into a different type of cell," Beck said.

The new study began with a chance discovery. Senior researcher Xiang-Dong Fu, a professor at the University of California, San Diego, had been studying a protein known as PTB for decades. PTB influences which genes within a cell are turned "on" or "off."

A few years ago, Fu's lab was studying the workings of PTB in connective tissue cells called fibroblasts, and a member of his team suggested an alternative method: Creating a line of fibroblasts that permanently lacked PTB.

What happened next was completely unexpected, Fu said: After a couple of weeks in the lab dish, nearly all of the fibroblasts had converted into neurons.

Fu said his first thought was, "Wow."

PTB exists in many types of cells, but not in neurons, Fu explained. Instead, it seems the protein tells the genes within a cell whether it should become a neuron or not.

"It's a master regulator of neurogenesis that we just stumbled upon," Fu said.

That naturally brought up the question of whether silencing PTB might produce new neurons in a diseased brain. As an initial step to find out, Fu's team turned to a mouse model of Parkinson's.

The researchers took a non-infectious virus -- basically a viral "shell," Beck explained -- and outfitted it to carry an artificial piece of DNA designed to deplete PTB within cells. They delivered it directly into the midbrain of the lab mice.

The treatment worked: It turned a subset of the animals' astrocytes -- support cells in the brain -- into dopamine-producing neurons. From there, brain dopamine levels rose, and the animals' movement symptoms resolved.

The findings were published June 24 in the journal Nature.

Many questions must be answered before the approach can be studied in humans. Fu said the next step is to figure out what treatment "dose" is optimal in lab mice, and eventually it will have to be studied in larger animals.

A major safety question, Fu said, is whether there is a risk of producing too many dopamine neurons.

Overgrowth of neurons in the brain would be bad, Beck agreed. "You have to be sure the process is reliable and safe," he said.

Beck also stressed the limitations of a therapy that replaces dopamine neurons. "It would not be a cure for Parkinson's," he said. "It would address symptomatic relief."

That's because Parkinson's is a brain disease, and not only a disease of dopamine loss, Beck explained. So replacing dopamine neurons would not be a magic bullet.

In addition, Parkinson's symptoms are not only movement-related. They range widely and include depression, irritability and trouble with memory and thinking skills.

Replacing dopamine neurons could be expected to ease movement symptoms -- as current medications that boost dopamine do, Beck said. Those drugs do not, however, improve non-movement symptoms.

But these early findings could have implications beyond Parkinson's disease. Fu said the same approach to blocking PTB could also be tested against other conditions where neurons die -- including Alzheimer's, Huntington's and stroke.

More information

Visit the Parkinson's Foundation for more on Parkinson's disease.